US-based scientists at the Flatiron Institute's Center for Computational Biology (CCB) and Princeton...
Machine-learning model may help detect undiagnosed dementia
A study led by the University of Plymouth in the UK has indicated the potential use of a machine-learning model to detect undiagnosed dementia in primary care.
Australian researchers develop test to detect melanoma in early stages
Researchers at the Edith Cowan University (ECU), Australia, have developed a blood test that detects melanoma in its early stages.
AI accurately predicts genetic mutation effects in genome dark matter
US-based scientists at the Flatiron Institute's Center for Computational Biology (CCB) and Princeton University have created a machine learning framework, called ExPecto, which can predict the effects of mutations in the ‘dark matter’ regions of the human genome and could one day aid in drug therapy selection.
Alliance Global to market Biocept liquid biopsy tests
US-based molecular diagnostics company Biocept has signed a provider agreement for Alliance Global to market and distribute its Target Selector liquid biopsy tests in the UAE, certain Middle East countries, North & Sub-Saharan Africa and the South East Asia (MEAA) region.
Blood test for prostate cancer cell levels can detect therapy response
A new study led by the Institute of Cancer Research (ICR) has found that a test used to analyse blood samples for traces of tumour cells can aid in the identification of therapy response in advanced prostate cancer patients.
Study finds blood test can predict lung cancer risk
A study by the International Agency for Research on Cancer (IARC) in France has found a new blood test for four protein biomarkers can better identify people who will develop lung cancer in the future.
US researchers create device to detect mosquito-borne diseases
Researchers at SMK Diagnostics, the Purdue University startup, have developed a biosensor that can quickly identify mosquito-borne diseases prior to the transmission of the viruses to humans.
Volition expands clinical development of Nu.Q to Asia Pacific
Belgium-based cancer diagnostics firm Volition has expanded the clinical trial programme of its Nu.Q platform, being developed to detect colorectal cancer, to the Asia Pacific Region.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.